Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma
Cemiplimab, even in combination with radiotherapy, can be effectively and safely administered to very elderly patients with metastatic cutaneous SCC. This case supports the consideration of immunotherapy, even for a limited duration, as a practical option in the management of advanced cutaneous SCC in elderly patients, expanding the potential treatment strategies for this population.
Authors
- Lorenzo Antonuzzo (ORCID: https://orcid.org/0000-0003-3349-5604)
- Giulia Venturi (ORCID: https://orcid.org/0000-0002-1624-8946)
- Laura Doni
- Isacco Desideri (ORCID: https://orcid.org/0000-0002-9880-8387)
- Serena Pillozzi (ORCID: https://orcid.org/0000-0001-8861-8718)
- Ismaela Anna Vascotto
- Adriana Guarino
- Elisabetta Gambale
Institutions
- Azienda Ospedaliero-Universitaria Careggi (IT)
- University of Florence (IT)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21873/cdp.10381
- Citations
- 1
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39